The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

35 articles for JL Methot


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Potent benzoazepinone¿-secretase modulators with improved bioavailability.EBI
Merck Research Laboratories
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor.EBI
Merck Research Laboratories
Triazoloamides as potent¿-secretase modulators with reduced hERG liability.EBI
Merck Research Laboratories
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).EBI
Merck Research Laboratories
Triazoles as¿-secretase modulators.EBI
Merck Research Laboratories
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2).EBI
Merck Research Laboratories
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors.EBI
Merck Research Laboratories
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1EBI
Merck
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors.EBI
Merck
Projected Dose Optimization of Amino- and Hydroxypyrrolidine Purine PI3Kδ Immunomodulators.EBI
Merck
Discovery of a new series of PI3K-δ inhibitors from Virtual Screening.EBI
Merck
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds.EBI
Merck
Identification of Potent Reverse Indazole Inhibitors for HPK1.EBI
Merck
Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors.EBI
Merck
Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors.EBI
Merck
Discovery of 1-(1H-Pyrazolo[4,3-c]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of Cancers.EBI
Merck
Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow.EBI
Merck
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability.EBI
TBA
Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeys.EBI
Merck Research Laboratories Boston
COMPOUND BASED ON QUINAZOLINE-SUBSTITUTED GLUTARIMIDE SKELETON AND USE THEREOFBDB
Gluetacs Therapeutics (Shanghai) Co.
Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugsBDB
Intra-Cellular Therapies
ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERSBDB
Gilgamesh Pharmaceuticals
Pyrrole-substituted indolone derivative or pharmaceutically acceptable salts thereof, and preparation method therefor and application thereofBDB
Suzhou Genhouse Pharmaceutical Co.
MODULATORS OF FPR1 AND METHODS OF USING THE SAMEBDB
Biofront
Potent Inhibition of SARS-CoV-2 nsp14 BDB
University of Montpellier
Compounds, compositions and methodsBDB
Denali Therapeutics
Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitorsBDB
University of Michigan
Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitorsBDB
UniversitÄT Duisburg-Essen
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomasBDB
Celgene Quanticel Research
Aminoindazole derivatives as sodium channel inhibitorsBDB
Almirall
Hydroxylated aminotriazole derivatives as ALX receptor agonistsBDB
Actelion Pharmaceuticals
N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamidesBDB
Novartis
A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide, and affinity purification of casein kinase I from bovine testis.BDB
Nagoya University School of Medicine
Synthesis and SAR exploration of dinapsoline analogues.BDB
Bristol-Myers Squibb Pharmaceutical Research Institute
Cloning and characterization of the human GABAA receptor alpha 4 subunit: identification of a unique diazepam-insensitive binding site.BDB
Cocensys